NGM BIOPHARMACEUTICALS INC Common Stock, Value, Issued
NGM BIOPHARMACEUTICALS INC had Common Stock, Value, Issued of $83.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2024-03-11
- 2023-12-31: Common Stock, Value, Issued $83.00K.
- 2023-09-30: Common Stock, Value, Issued $83.00K.
- 2023-06-30: Common Stock, Value, Issued $83.00K.
- 2023-03-31: Common Stock, Value, Issued $82.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2023-12-31 | $83.00K 10-K · filed 2024-03-11 |
| 2023-09-30 | $83.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $83.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $82.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $82.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | $82.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $79.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $78.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $78.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $78.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $77.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $77.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $71.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $69.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $69.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $68.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $67.00K 10-K · filed 2021-03-15 |
| 2019-09-30 | $66.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $66.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $7.00K 10-Q · filed 2019-05-16 |
| 2018-12-31 | $7.00K 10-K · filed 2020-03-17 |